E. Alecock

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

J. Kremer, P. Emery, E. Keystone, 2008, Annals of the rheumatic diseases.

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

J. Smolen, E. Alecock, C. Ramos-Remus, 2008, The Lancet.

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

M. Genovese, M. Tomšič, J. Gu, 2009, Annals of the rheumatic diseases.

An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance

A. Humar, R. Freeman, C. Payá, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High‐risk CMV D+/R− Transplant Recipients

M. Pescovitz, A. Humar, C. Payá, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Surveillance Study of Adenovirus Infection in Adult Solid Organ Transplant Recipients

Deepali Kumar, M. Pescovitz, A. Humar, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients.

A. Humar, C. Payá, E. Alecock, 2005, The Journal of infectious diseases.

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

M. Genovese, J. Gómez-Reino, E. Nasonov, 2008, Arthritis and rheumatism.

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.

A. Humar, C. Payá, E. Alecock, 2005, The Journal of infectious diseases.